C-MYC is related to GATA3 expression and associated with poor prognosis in nodal peripheral T-cell lymphomas.
作者信息
Manso Rebeca, Bellas Carmen, Martín-Acosta Paloma, Mollejo Manuela, Menárguez Javier, Rojo Federico, Llamas Pilar, Piris Miguel A, Rodríguez-Pinilla Socorro M
机构信息
Pathology Department, Fundación Jiménez Díaz, UAM, Madrid.
Pathology Department, Hospital Universitario Puerta de Hierro, Madrid.
出版信息
Haematologica. 2016 Aug;101(8):e336-8. doi: 10.3324/haematol.2016.143768. Epub 2016 May 5.
Abstract
摘要
相似文献
1
C-MYC is related to GATA3 expression and associated with poor prognosis in nodal peripheral T-cell lymphomas.C-MYC与GATA3表达相关，并与淋巴结外周T细胞淋巴瘤的不良预后相关。
Haematologica. 2016 Aug;101(8):e336-8. doi: 10.3324/haematol.2016.143768. Epub 2016 May 5.
2
p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome.p53过表达可识别出一部分具有独特生物学特征且临床预后较差的结外外周T细胞淋巴瘤。
J Pathol. 2001 Oct;195(3):361-6. doi: 10.1002/path.945.
3
GATA3 expression correlates with poor prognosis and tumor-associated macrophage infiltration in peripheral T cell lymphoma.GATA3表达与外周T细胞淋巴瘤的不良预后及肿瘤相关巨噬细胞浸润相关。
Oncotarget. 2016 Oct 4;7(40):65284-65294. doi: 10.18632/oncotarget.11673.
4
Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.Gata3、c-Myc与Notch在双阳性胸腺细胞恶性转化中的协同作用。
Mol Immunol. 2008 Jun;45(11):3085-95. doi: 10.1016/j.molimm.2008.03.018. Epub 2008 May 8.
5
Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.c-Myc和Ki-67表达均为鼻型结外NK/T细胞淋巴瘤患者的预测性标志物：一项中国的回顾性研究
Pathol Res Pract. 2014 Jun;210(6):351-6. doi: 10.1016/j.prp.2014.02.004. Epub 2014 Feb 23.
6
Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.外周T细胞淋巴瘤中的标志物表达：一种提议的临床病理预后评分
J Clin Oncol. 2006 Jun 1;24(16):2472-9. doi: 10.1200/JCO.2005.03.6327. Epub 2006 Apr 24.
7
Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.血清IgA水平、单核细胞计数和国际预后指数与HTLV-I阴性淋巴结外周T细胞淋巴瘤患者的总生存期独立相关。
Ann Hematol. 2014 Jul;93(7):1185-91. doi: 10.1007/s00277-014-2025-0. Epub 2014 Feb 14.
8
Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases.免疫组织化学在MYC阳性侵袭性B细胞淋巴瘤基因检测时代的作用：一项209例病例的研究
J Clin Pathol. 2016 Mar;69(3):266-70. doi: 10.1136/jclinpath-2015-203002. Epub 2015 Aug 25.
9
Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis.结外NK/T细胞淋巴瘤与外周T细胞淋巴瘤的比较分析：临床特征和预后的显著差异
Eur J Haematol. 2008 Jan;80(1):55-60. doi: 10.1111/j.1600-0609.2007.00978.x. Epub 2007 Nov 20.
10
[Expression of GATA3 and bcl-11b in peripheral T-cell lymphoma and their clinical significance].GATA3和bcl-11b在外周T细胞淋巴瘤中的表达及其临床意义
Zhonghua Bing Li Xue Za Zhi. 2021 Aug 8;50(8):904-909. doi: 10.3760/cma.j.cn112151-20201224-00955.
引用本文的文献
1
Angioimmunoblastic T-cell lymphoma harboring a t(8;14)(q24;q11.2)/TCR::MYC translocation that presented with intestinal infiltration.伴有t(8;14)(q24;q11.2)/TCR::MYC易位且表现为肠道浸润的血管免疫母细胞性T细胞淋巴瘤。
Ann Hematol. 2025 Jan;104(1):835-840. doi: 10.1007/s00277-024-06148-2. Epub 2024 Dec 18.
2
Cellular redox homeostasis maintained by malic enzyme 2 is essential for MYC-driven T cell lymphomagenesis.苹果酸酶 2 维持的细胞氧化还原稳态对于 MYC 驱动的 T 细胞淋巴瘤发生是必不可少的。
Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2217869120. doi: 10.1073/pnas.2217869120. Epub 2023 May 30.
3
PTCL, NOS: An update on classification, risk-stratification, and treatment.外周T细胞淋巴瘤，非特指型：分类、风险分层及治疗的最新进展
Front Oncol. 2023 Feb 9;13:1101441. doi: 10.3389/fonc.2023.1101441. eCollection 2023.
4
Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma.异常表达的 MYCN 驱动 EZH2 作为转录激活因子，导致外周 T 细胞淋巴瘤发生癌基因劫持。
Blood. 2022 Dec 8;140(23):2463-2476. doi: 10.1182/blood.2022016428.
5
The Role of NOTCH1, GATA3, and c-MYC in T Cell Non-Hodgkin Lymphomas.NOTCH1、GATA3和c-MYC在T细胞非霍奇金淋巴瘤中的作用
Cancers (Basel). 2022 Jun 4;14(11):2799. doi: 10.3390/cancers14112799.
6
A preclinical model of peripheral T-cell lymphoma GATA3 reveals DNA damage response pathway vulnerability.外周 T 细胞淋巴瘤 GATA3 的临床前模型揭示了 DNA 损伤反应通路的脆弱性。
EMBO Mol Med. 2022 Jun 8;14(6):e15816. doi: 10.15252/emmm.202215816. Epub 2022 May 5.
7
Targeting the DNA Damage Response to Increase Anthracycline-Based Chemotherapy Cytotoxicity in T-Cell Lymphoma.靶向 DNA 损伤反应以提高 T 细胞淋巴瘤中基于蒽环类药物的化疗细胞毒性。
Int J Mol Sci. 2022 Mar 30;23(7):3834. doi: 10.3390/ijms23073834.
8
Association between c-Myc Expression with Clinicopathological Features in T And NK Cell Lymphomas.c-Myc 表达与 T 和 NK 细胞淋巴瘤临床病理特征的关系。
Asian Pac J Cancer Prev. 2021 Dec 1;22(12):4011-4016. doi: 10.31557/APJCP.2021.22.12.4011.
9
T-Cell Acute Lymphoblastic Leukemia-Current Concepts in Molecular Biology and Management.T细胞急性淋巴细胞白血病——分子生物学与治疗的当前概念
Biomedicines. 2021 Nov 4;9(11):1621. doi: 10.3390/biomedicines9111621.
10
Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers.大细胞形态、CMYC+肿瘤细胞和 PD-1+肿瘤细胞/强烈 PD-L1+细胞反应是具有滤泡辅助 T 细胞标志物的结外 T 细胞淋巴瘤的重要预后因素。
Diagn Pathol. 2021 Nov 6;16(1):101. doi: 10.1186/s13000-021-01163-7.
本文引用的文献
1
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.基因表达谱可明确外周 T 细胞淋巴瘤的生物学和预后亚群。
Blood. 2014 May 8;123(19):2915-23. doi: 10.1182/blood-2013-11-536359. Epub 2014 Mar 14.
2
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.GATA-3 表达鉴定出一组具有独特分子和临床特征的高风险、NOS 侵袭性 T 细胞淋巴瘤亚群。
Blood. 2014 May 8;123(19):3007-15. doi: 10.1182/blood-2013-12-544809. Epub 2014 Feb 4.
3
MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma.miR-187 过表达与肿瘤进展相关，并决定外周 T 细胞淋巴瘤对硼替佐米的敏感性。
Leukemia. 2014 Apr;28(4):880-7. doi: 10.1038/leu.2013.291. Epub 2013 Oct 9.
4
GATA-3 controls the maintenance and proliferation of T cells downstream of TCR and cytokine signaling.GATA-3 控制着 TCR 和细胞因子信号下游 T 细胞的维持和增殖。
Nat Immunol. 2013 Jul;14(7):714-22. doi: 10.1038/ni.2623. Epub 2013 May 26.
5
Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas.T 细胞受体-β F1 和/或 ezrin 表达缺失与结外外周 T 细胞淋巴瘤的不良预后相关。
Blood Cancer J. 2013 Apr 19;3(4):e111. doi: 10.1038/bcj.2013.10.
6
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.血管免疫母细胞性 T 细胞淋巴瘤的临床病理特征：国际外周 T 细胞淋巴瘤项目分析。
J Clin Oncol. 2013 Jan 10;31(2):240-6. doi: 10.1200/JCO.2011.37.3647. Epub 2012 Aug 6.
7
TCR-dependent transformation of mature memory phenotype T cells in mice.TCR 依赖性的成熟记忆表型 T 细胞在小鼠中的转化。
J Clin Invest. 2011 Oct;121(10):3834-45. doi: 10.1172/JCI37210. Epub 2011 Sep 19.
8
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.外周 T 细胞淋巴瘤，非特指型：国际外周 T 细胞淋巴瘤项目的 340 例报告。
Blood. 2011 Mar 24;117(12):3402-8. doi: 10.1182/blood-2010-09-310342. Epub 2011 Jan 26.
9
10
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.改善外周 T 细胞淋巴瘤诊断和血管免疫母细胞性 T 细胞淋巴瘤预后的分子标志物。
Blood. 2010 Feb 4;115(5):1026-36. doi: 10.1182/blood-2009-06-227579. Epub 2009 Nov 18.
Zotero 插件